ICU Medical, Inc. ICUI
Set alert
161.49 USD -0.89 -0.55%
As of Nov 3, 2:45 PM ET
160.97 Day range 166.48
113.37 52-week range 192.85
- YTD
- +13.19%
- 1 year
- +31.44%
- Open
- 163.00
- Prev close
- 162.38
- Mkt cap
- 4.03B
- Vol
- 74.22K
- Avg vol
- 255.62K
- EPS
- 1.19
- P/E
- 135.57
- Div yield
- 0.00%
More statistics
- Low
- 160.97
- High
- 166.48
- Forward P/E
- 16.83
- Beta
- 0.88
- Short ratio
- 6.84
- Inst. own
- 115.97%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 164.22
- 200-d avg
- 148.59
- 1y target
- 193.38
3M chart
Events in this range
- Aug 6, 2026Earnings: 2.37; estimate 1.91; surprise 24.08%
- Aug 7, 2026Rating: Needham · Buy → Buy
- Aug 7, 2026Rating: BTIG · Buy → Buy
- Aug 7, 2026Rating: Piper Sandler · Overweight → Overweight
Signals (17)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Nov 3, 2026 | 5 hours ago |
| SMA: Bearish | Nov 2, 2026 | 1 day ago |
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 28, 2026 | 6 days ago |
| SMA: Bearish | Oct 27, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| SMA: Bullish | Oct 12, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 24, 2026 | 1 month ago |
| RSI: Oversold | Sep 17, 2026 | 1 month ago |
| RSI: Oversold | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bullish | Sep 4, 2026 | 2 months ago |
| SMA: Bearish | Sep 3, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 21, 2026 | 2 months ago |
| RSI: Overbought | Aug 19, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
Financial health
Altman Z-Score
2.39 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 4
- Return on Equity 2
- Return on Assets 3
- Debt / Equity 2
- P/E 1
- P/B 4
Valuation
P/E 4804×
FY 2016 5y median -32.1× FY 2025
P/S 1.6×
FY 2016 5y median 1.6× FY 2025
P/B 1.7×
FY 2016 5y median 1.8× FY 2025
P/FCF 38.3×
FY 2016 5y median 30.4× FY 2025
EV/EBITDA 14.9×
FY 2016 5y median 19.7× FY 2025
EV/Sales 2.1×
FY 2016 5y median 2.1× FY 2025
FCF Yield 2.6%
FY 2016 5y median 3.0% FY 2025
Profitability
Gross Margin 36.8%
FY 2016 5y median 34.6% FY 2025
Operating Margin 4.8%
FY 2016 5y median 1.8% FY 2025
Net Margin 0.0%
FY 2016 5y median -1.3% FY 2025
ROE 0.0%
FY 2016 5y median -1.4% FY 2025
ROIC 0.7%
FY 2016 5y median 0.7% FY 2025
ROA 0.0%
FY 2016 5y median -0.7% FY 2025
Growth (YoY)
Revenue -6.4%
FY 2016 FY 2025
Operating Income 148.9%
FY 2016 FY 2025
EPS (diluted) 100.6%
FY 2016 FY 2025
Free Cash Flow -26.4%
FY 2016 FY 2025
Financial Health
Current Ratio 2.4×
FY 2016 5y median 2.5× FY 2025
Quick Ratio 1.1×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 0.7×
FY 2016 5y median 0.8× FY 2025
Net Debt / EBITDA 3.5×
FY 2016 5y median 5.1× FY 2025
Interest Coverage 1.0×
FY 2016 5y median 0.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
